中文     русский     Home | Set As Homepage
  
 
Our News
  Zizhu’s misoprostol receives WHO prequalification2016/11/24
  Mifepristone200mg Tablets approved by WHO Prequalification2016/8/16
  TESTOSTERONE has received CEP2016/1/7
  APIs of QZP approved by COFEPRIS of Mexico2015/7/6
  CRZP has received WHO prequalification2014/11/6
  APIs of QZP approved by FDA2014/11/2
  APIs of QZP approved by WHO-PQ2013/9/3
  API China & PHARMPACK & SINOPHEX 20162016/4/18
  First reproductive health API receives WHO prequalification2013/7/16
  BZP has renamed as CRZP2013/7/16
  Zizhu Passed WHO and FDA GMP Inspections2012/12/6
  2011 China Health Annual Billboard2012/1/30
  Qinhuangdao Zizhu rewarded the API GMP2012/1/12
  API GMP for  Testosterone2012/1/12
  Zizhu has been rewarded the OHSAS18001 certificate by TÜVAnlagent...2011/8/16
  Zizhu passed the reevaluation of the ISO9001:2000 quality system on No...2011/8/16
  Zizhu pharmaceutical obtained ISO10012 certificate2011/8/16
  Levonorgestrel Tablets(0.75mg) and Mifepristone were awarded the “ Fa...2011/8/16
  Zizhu successfully passed the ISO14001 environmental system reevaluati...2011/8/16
Industry News
Top News
  Mifepristone200mg Tablets...
Mifepristone200mg Tablets approved by WHO Prequalification
  APIs of QZP approved by F...
APIs of QZP approved by FDA
Contact:   Tel: +86-10-62250847  Fax: +86-10-62245401
 E-Mail:  zizhu@zizhu-pharm.com
China  Resources  Zizhu  Pharmaceutical  Co.,Ltd Home | News | About us | Health & Wellness | Products | R & D | Foreign Affairs Copyright© 2011-2021